Unlocking Better Health: How Understanding Healthcare Utilization Can Improve Your Well-being
"A closer look at key studies reveals how factors like mental health, specific conditions, and treatment policies dramatically impact healthcare access and costs, paving the way for more effective and equitable healthcare solutions."
In today's complex healthcare landscape, understanding how resources are utilized is more critical than ever. Healthcare utilization encompasses everything from hospital visits and medication use to specialized treatments and emergency care. By examining patterns in healthcare utilization, we can identify areas where improvements are needed, ensure resources are allocated effectively, and ultimately enhance patient outcomes.
Several recent studies shed light on various aspects of healthcare utilization across different populations and conditions. These studies, presented at a Value in Health conference, delve into the impact of mental health on chronic conditions, the challenges of managing diseases like Hepatitis C in diverse healthcare systems, and the economic burdens faced by patients with inflammatory bowel disease (IBD).
By exploring these findings, we can gain valuable insights into the factors that influence healthcare access, costs, and quality. This knowledge is essential for patients, healthcare providers, and policymakers alike, as it informs strategies to optimize care, reduce disparities, and promote overall well-being. Let's delve into these key studies and uncover what they reveal about the current state of healthcare utilization.
IBS and Related Health Problems
People with irritable bowel syndrome often have other health problems. The National Institute of Diabetes and Digestive and Kidney Diseases lists chronic-pain conditions such as fibromyalgia, chronic fatigue syndrome, and chronic pelvic pain among them. It also identifies digestive diseases such as dyspepsia and gastroesophageal reflux disease, along with mental disorders including anxiety, depression, and somatic symptom disorder.
Measuring Healthcare Utilization
Research on IBS healthcare utilization has examined outpatient patterns and their relationship to symptom burden. A 2024 study described limited information about utilization patterns for prevalent gastrointestinal conditions and aimed to identify those patterns among outpatients. Another observational study reported that patients receiving IBS-Smart and/or Trio-Smart had lower captured resource utilization and greater chart-level diagnostic persistence than patients receiving standard care alone, although the result reflects an association rather than an established causal effect.
Developing the IBS Evidence Base
The study of IBS has expanded from describing epidemiology and natural history to examining healthcare seeking and risk factors. A review in Gastroenterology Clinics of North America critically assessed relevant literature identified through PubMed and Embase searches. The Walkerton Health Study also connected waterborne exposure to acute gastroenteritis at a mean age of 11.6 years with adult IBS in a subgroup followed from childhood into adulthood.
The Impact of Depression on Healthcare for Individuals with IBS
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that affects millions worldwide. What might be surprising is the significant connection between IBS and mental health, particularly depression. A study presented at the Value in Health conference investigated how comorbid depression impacts healthcare utilization and costs among individuals with IBS enrolled in a multi-state Medicaid program.
- Increased Healthcare Utilization: Individuals with both IBS and depression had significantly greater all-cause healthcare utilization (220.21 vs. 205.52, p<0.001) and IBS-related healthcare utilization (18.86 vs. 14.29, p<0.001) compared to those with IBS alone.
- Higher Costs: The IBS and depression group also incurred higher IBS-specific healthcare expenditures ($2,085 vs. $1,556, p<0.001).
- Key Drivers: The increased utilization and costs were driven by inpatient services, outpatient services, emergency room visits, and prescription drug use.
Hepatitis C: Current Evidence
The World Health Organization reports that most hepatitis C infections occur through exposure to blood, including unsafe injections and procedures, unscreened blood transfusions, needle and syringe sharing, and some sexual practices. WHO estimates that 47 million people have chronic hepatitis C virus infection globally and that about 0.9 million new infections occur each year. It also estimates that approximately 239,000 people died from hepatitis C in 2024, while direct-acting antiviral medicines can cure more than 95% of infected people, although access to diagnosis and treatment remains low.
When Utilization Signals Unmet Need
People with IBS have higher healthcare utilization than non-IBS controls, including medication use and abdominal surgery. The cited study also found that people who consult healthcare providers differ according to whether they have an IBS diagnosis, including differences in sex distribution and symptom profiles. These findings raise concern about potentially unnecessary medical and surgical treatment and show that utilization does not always represent effective diagnosis or symptom management.
IBS Compared With Crohn’s Disease
Crohn’s disease and IBS create different healthcare-utilization questions. The National Institute of Diabetes and Digestive and Kidney Diseases estimates that 1 million people in the United States have Crohn’s disease and reports that the condition has become more common in the United States and elsewhere. By contrast, research on IBS has examined frequent use of diagnostic tests and procedures, as well as differences in symptoms, healthcare visits, well-being, symptom management, and treatment satisfaction.
Understanding Adherence and Its Impact on Biologic Treatments for IBD
Biologic therapies have revolutionized the treatment of IBD, offering new hope for patients who haven't found relief through traditional medications. However, the effectiveness of these treatments hinges on patient adherence. A systematic review explored real-world evidence on adherence with biologics in IBD patients within the United States, shedding light on the challenges and opportunities in this area.
Costs of Care in Constipation Disorders
IBS with constipation and chronic idiopathic constipation are described as common functional intestinal disorders affecting people of all ages. A 2025 study assessed differences in healthcare resource utilization and total costs of care between these conditions. The study specifically addressed the limited comparative evidence concerning the economic benefits of treating IBS-C and chronic idiopathic constipation in older adults.
The IBS Market Outlook
Industry reporting for 2026 is tracking IBS prevalence, disorders of gut-brain interaction data, microbiome trends, market growth, and digestive-health research. Verified Market Research reports that the IBS market was valued at $3.80 billion in 2025 and projects it will reach $5.70 billion by 2033, with a 5.2% compound annual growth rate. Another market report frames the sector’s outlook around treatment trends and growth opportunities across the 2026–2035 forecast period.
Real-World Testing and Utilization
A real-world observational study examined healthcare resource utilization after IBS-Smart and Trio-Smart testing in patients with suspected IBS. The study reported lower captured resource utilization and greater chart-level diagnostic persistence among patients receiving IBS-Smart and/or Trio-Smart than among those receiving standard care alone. Its authors emphasized that these findings are real-world associations rather than causal proof and do not establish that the testing itself caused the observed differences.